American Journal of Obstetrics & Gynecology
Volume 185, Issue 5 , Pages 1039-1043, November 2001

Factors associated with fetal demise in fetal echogenic bowel

Presented at the Twenty-first Annual Meeting of the Society for Maternal-Fetal Medicine, Reno, Nev, February 5-10, 2001.

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, New York Presbyterian Hospital-Weill Medical College of Cornell University. New York, NY

Correspondence: Huda B. Al-Kouatly, MD, New York Hospital-Weill Medical College of Cornell University, Department of Obstetrics and Gynecology, 525 East 68th St, J-130, New York, NY 10021. E-mail: hbalkoua@mail.med.cornell.edu.

Abstract 

Objective: The purpose of this study was to determine risk factors associated with intrauterine fetal demise in fetuses with unexplained echogenic bowel that is diagnosed in the second trimester. Study Design: A retrospective case-control study compared fetuses with echogenic bowel and fetal demise with fetuses with echogenic bowel who were live born. Fetuses affected with cystic fibrosis, aneuploidy, or congenital infection and fetuses diagnosed with major anomalies were excluded. Variables examined in the determination of risk factors for intrauterine fetal demise included intrauterine growth restriction, oligohydramnios, elevated maternal serum alpha-fetoprotein levels, and elevated maternal serum β-hCG levels. Statistical analysis was performed with the Fisher exact test, Student t test, and logistic regression analysis. Results: One hundred fifty-six fetuses met the inclusion criteria. There were 9 cases of intrauterine fetal demise and 147 live born control fetuses. The median gestational age of intrauterine fetal demise was 22.0 weeks (range, 17-39 weeks). Intrauterine growth restriction occurred more frequently in cases of intrauterine fetal demise than in live born infants (22.2% vs 0.7%; P = .009), as did oligohydramnios (44.4% vs 2.0%; P < .001) and elevated maternal serum alpha-fetoprotein levels (80.0% vs 7.7%; P: = .001). With the use of logistic regression analysis, elevated maternal serum alpha-fetoprotein was the strongest independent risk factor that was associated with intrauterine fetal demise (odds ratio, 39.48; 95% CI, 11.04%-141.25%). Conclusion: In our series, there was a 5.8% incidence of intrauterine fetal demise in fetuses with unexplained echogenic bowel. Elevated maternal serum alpha-fetoprotein is the strongest predictor of fetal demise in fetal echogenic bowel. (Am J Obstet Gynecol 2001;185:1039-43.)

Keywords:  Echogenic bowel, fetal demise, maternal serum alpha-fetoprotein, oligohydramnios, growth restriction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Reprints not available from author.

PII: S0002-9378(01)98198-0

doi:10.1067/mob.2001.117641

American Journal of Obstetrics & Gynecology
Volume 185, Issue 5 , Pages 1039-1043, November 2001